These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12085194)
1. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells. McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252 [TBL] [Abstract][Full Text] [Related]
4. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta. Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells. Danforth DN; Sgagias MK Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237 [TBL] [Abstract][Full Text] [Related]
6. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496 [TBL] [Abstract][Full Text] [Related]
9. Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells. Sathyamoorthy N; Gilsdorf JS; Wang TT Anticancer Res; 1998; 18(4A):2449-53. PubMed ID: 9703891 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Liu C; Tsao MS; Grisham JW Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400 [TBL] [Abstract][Full Text] [Related]
11. Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. O'Keefe RJ; Crabb ID; Puzas JE; Rosier RN J Orthop Res; 1994 May; 12(3):299-310. PubMed ID: 8207583 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 (TGF beta 1) enhances apoptosis in human papillomavirus type 16-immortalized human ectocervical epithelial cells. Rorke EA; Jacobberger JW Exp Cell Res; 1995 Jan; 216(1):65-72. PubMed ID: 7529191 [TBL] [Abstract][Full Text] [Related]
13. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. Johnston PG; Rondinone CM; Voeller D; Allegra CJ Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474 [TBL] [Abstract][Full Text] [Related]
14. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta. Havrilesky LJ; Hurteau JA; Whitaker RS; Elbendary A; Wu S; Rodriguez GC; Bast RC; Berchuck A Cancer Res; 1995 Feb; 55(4):944-8. PubMed ID: 7531618 [TBL] [Abstract][Full Text] [Related]
15. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties. Serrero G; Zhou J; Mills D; LePak N J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484 [TBL] [Abstract][Full Text] [Related]
16. Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cells. Lambrecht V; Le Bourhis X; Toillon RA; Boilly B; Hondermarck H Exp Cell Res; 1998 Dec; 245(2):239-44. PubMed ID: 9851863 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Danforth DN; Sgagias MK Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620 [TBL] [Abstract][Full Text] [Related]
18. Insulin receptor expression and function in human breast cancer cell lines. Milazzo G; Giorgino F; Damante G; Sung C; Stampfer MR; Vigneri R; Goldfine ID; Belfiore A Cancer Res; 1992 Jul; 52(14):3924-30. PubMed ID: 1617668 [TBL] [Abstract][Full Text] [Related]
19. Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cells. Koli KM; Arteaga CL Cancer Res; 1997 Mar; 57(5):970-7. PubMed ID: 9041203 [TBL] [Abstract][Full Text] [Related]
20. Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells. Firth SM; Fanayan S; Benn D; Baxter RC Biochem Biophys Res Commun; 1998 May; 246(2):325-9. PubMed ID: 9610357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]